Zuclotrip-Acuphase 50 mg Injection 1 ml
₹351*
MRP ₹390
10% off
₹331*
MRP ₹390
15% CB
₹59 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Zuclotrip-Acuphase 50 mg Injection 1 ml belongs to a class of medications called antipsychotics used to treat schizophrenia (a mental illness) and other psychotic disorders. Additionally, Zuclotrip-Acuphase 50 mg Injection 1 ml may be used in the initial treatment of mania over the short term. Schizophrenia is a mental disorder that affects the ability of a person to feel, think and behave clearly.
Zuclotrip-Acuphase 50 mg Injection 1 ml contains Zuclopenthixol which works by inhibiting the dopamine (chemical messenger) receptors in the brain. Dopamine is involved in regulating mood, behaviour and emotions. Thereby, Zuclotrip-Acuphase 50 mg Injection 1 ml helps in controlling psychotic illness by preventing the overactivity of dopamine in the brain. Thus, it helps in improving feelings, disturbed thoughts and behaviour.
Zuclotrip-Acuphase 50 mg Injection 1 ml will be administered by a healthcare professional; do not self-administer. Some people may experience sleepiness, akathisia (inability to sit still or remain motionless), dry mouth, hyperkinesia (involuntary movements), hypokinesia (slow or diminished movements), constipation, muscle pain, tremor, or headache. Most of these side effects of Zuclotrip-Acuphase 50 mg Injection 1 ml do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.
If you are allergic to Zuclopenthixol or any other medicines, please tell your doctor. Zuclotrip-Acuphase 50 mg Injection 1 ml is not recommended for children. Zuclotrip-Acuphase 50 mg Injection 1 ml is not recommended during pregnancy unless clearly necessary because using it during the third trimester may cause adverse effects in the baby, such as breathing problems, muscle stiffness or weakness, shaking, etc. Zuclotrip-Acuphase 50 mg Injection 1 ml may be excreted in breast milk. Therefore, avoid taking Zuclotrip-Acuphase 50 mg Injection 1 ml if you are breastfeeding. Do not consume alcohol with Zuclotrip-Acuphase 50 mg Injection 1 ml as it may increase the sedative effects of alcohol. Drive only if you are alert, as Zuclotrip-Acuphase 50 mg Injection 1 ml may cause dizziness, double vision or drowsiness.
Zuclotrip-Acuphase 50 mg Injection 1 ml contains Zuclopenthixol used to treat schizophrenia (a mental illness) and other psychotic disorders. Additionally, Zuclotrip-Acuphase 50 mg Injection 1 ml may be used in the initial treatment of mania over the short term. Zuclotrip-Acuphase 50 mg Injection 1 ml inhibits the dopamine (chemical messenger) receptors in the brain. Dopamine is involved in regulating mood, behaviour and emotions. Thereby, Zuclotrip-Acuphase 50 mg Injection 1 ml helps in controlling psychotic illness by preventing the overactivity of dopamine in the brain. Thus, it helps in improving feelings, disturbed thoughts and behaviour. Also, Zuclotrip-Acuphase 50 mg Injection 1 ml produces a calming effect and controls hallucinations, aggression and delusions (false beliefs).
If you are allergic to Zuclopenthixol or any other medicines, please tell your doctor. If you have liver, kidney, heart or thyroid problems, inform your doctor before taking Zuclotrip-Acuphase 50 mg Injection 1 ml. Zuclotrip-Acuphase 50 mg Injection 1 ml is not recommended for children. Zuclotrip-Acuphase 50 mg Injection 1 ml is not recommended during pregnancy unless clearly necessary as using it during third trimester may cause adverse effects in the baby such as breathing problems, muscle stiffness or weakness, shaking, etc. Zuclotrip-Acuphase 50 mg Injection 1 ml may be excreted in breast milk. Therefore, avoid taking Zuclotrip-Acuphase 50 mg Injection 1 ml if you are breastfeeding. Inform your surgeon, anaesthetist or dentist before any surgery that you are on treatment with Zuclotrip-Acuphase 50 mg Injection 1 ml. Do not consume alcohol with Zuclotrip-Acuphase 50 mg Injection 1 ml as it may increase sedative effects of alcohol. Drive only if you are alert as Zuclotrip-Acuphase 50 mg Injection 1 ml may cause dizziness, double vision or drowsiness.
Drug-Drug Interaction: Inform your doctor if you are taking high blood pressure-lowering medicines (hydralazine, doxazosin, guanethidine, methyldopa, clonidine), antibiotics (erythromycin, moxifloxacin), antimanic drug (lithium), heart-related medicines (quinidine, amiodarone, sotalol, dofetilide, digoxin), hormone (epinephrine), gastroprokinetic agent (cisapride), blood thinner (warfarin), antiemetic (metoclopramide), drugs to treat worm infections (piperazine), antiparkinson drug (levodopa), steroid (prednisolone) or other medicines.
Drug-Food Interaction: No interactions found.
Drug-Disease Interaction: If you have fits, high blood pressure, asthma, low potassium or magnesium in the blood, Parkinson’s disease, diabetes, blood clots, myasthenia gravis (muscle weakness), have a family history of irregular heartbeats or blood clots, liver, kidney, heart or thyroid problems, inform your doctor before taking Zuclotrip-Acuphase 50 mg Injection 1 ml.
Schizophrenia: It is a mental disorder that affects the ability of a person to feel, think and behave clearly. The symptoms include hallucinations, thought or movement disorders, delusions (misbelief), lack of emotion, sleep problems, isolation from family and friends, and difficulty in daily activities.
Mania: It is a mental condition which causes intense excitement, high energy and delusions (misbeliefs). Mania may occur due to lack of sleep or changes in sleep patterns, high levels of stress and alcohol intake. Consult a doctor immediately if you have any self-harming or suicidal thoughts.
Alcohol
Unsafe
Avoid consumption of alcohol with Zuclotrip-Acuphase 50 mg Injection 1 ml as it may increase drowsiness.
Pregnancy
Caution
Zuclotrip-Acuphase 50 mg Injection 1 ml is not recommended for use during pregnancy unless clearly necessary. If Zuclotrip-Acuphase 50 mg Injection 1 ml is used during the third trimester, it may cause muscle stiffness and/or weakness, shaking, sleepiness, difficulty feeding, and breathing problems in the baby. Therefore, please consult a doctor if you are pregnant or planning for pregnancy before taking Zuclotrip-Acuphase 50 mg Injection 1 ml.
Breast Feeding
Unsafe
Zuclotrip-Acuphase 50 mg Injection 1 ml is not recommended for breastfeeding mothers as it may be excreted in breast milk. However, if you have concerns regarding this, please discuss them with your doctor.
Driving
Unsafe
There is a risk of dizziness, drowsiness or blurred vision after taking Zuclotrip-Acuphase 50 mg Injection 1 ml, especially at the beginning of your treatment. Avoid driving or operating machinery if you are not alert.
Liver
Consult your doctor
If you have liver problems, please consult your doctor before taking Zuclotrip-Acuphase 50 mg Injection 1 ml.
Kidney
Consult your doctor
If you have kidney problems, please consult your doctor before taking Zuclotrip-Acuphase 50 mg Injection 1 ml.
Children
Unsafe
Zuclotrip-Acuphase 50 mg Injection 1 ml is not recommended for children as safety and effectiveness were not established.
Country of origin
Manufacturer/Marketer address
We provide you with authentic, trustworthy and relevant information
Product Substitutes